REGEN BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-255.9K | $24.8K |
| FY2017 | — | $-1.4M | $270.0K |
| FY2018 | — | $-8.5M | $8.0K |
| FY2019 | — | $-8.8M | $7.9K |
| FY2020 | — | $-11.8M | $0 |
| FY2021 | — | $-5.1M | $727.2K |
| FY2022 | — | $-76.7M | $51.2K |
| FY2023 | — | $-4.9M | $121.0K |
| FY2024 | — | $-5.2M | $716 |
| FY2025 | — | $-6.3M | $69.6K |